News

A study published in Cell Stem Cell reveals that some mutations in blood stem cells might help protect against late-onset ...
A study published in Cell Stem Cell reveals that some mutations in blood stem cells might help protect against late-onset ...
Although Gentamicin is already approved by the U.S. Food and Drug Administration (FDA), its use in people is limited. It can ...
June is Alzheimer's and Brain Awareness Month. Colbie Schueneman, 6, is sharing her story with KIF1A, also known as KAND.
Among members of the Richardson family who carry a mutation in the PSEN1 gene, the average age when symptoms start is 39.
SynaptixBio, the only company licensed to commercialise a treatment for a rare but deadly disease, welcomes the announcement but says it lacks a detailed plan The government has announced that every ...
“The vast majority of adults truly need somewhere between seven and nine hours, and we offer that range because there is a ...
A groundbreaking study has revealed that a rare gene variant, APOE3-R136S, delays the onset of Alzheimer's disease by ...
R136S, or the “Christchurch mutation,” appears to protect against Alzheimer’s disease by suppressing inflammatory signaling ...